SGS has just completed an expansion project at its Glasgow facility, meaning it can provide increased biosafety testing for the biologics, drug development, and cell and gene therapy industries.
The project, which began back in March 2021 and was completed in September 2021, saw the footprint of the Glasgow facility increase by 550m2, meaning the facility now totals 3,100m2 in size and has a staff of 130 employees.
Sixteen BSL-2 laboratories have been added to our Glasgow facility. These laboratories contain a range of equipment, including BSL-2 cabinets, ELISA (enzyme-linked immunosorbent assay) technology, cell culture equipment for virus detection and real-time PCR (polymerase chain reaction) testing equipment.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.